<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The differences of the single clinical parameters (FMBS, FMPS, PD level ≥ 5 mm, CAL ≥ 4 mm) were evaluated (
 <xref rid="B13" ref-type="bibr" class="xref">Cosyn et al., 2013</xref>). For the same clinical score, the difference between TG and CG was carried out using the Mann–Whitney U test both at T0 and T1 (
 <italic class="italic">p</italic> &lt; 0.05). Within each group, the differences in all clinical scores between T0 and T1 were evaluated using the Wilcoxon signed-rank test (
 <italic class="italic">p</italic> &lt; 0.05). The difference in the rate of adverse events between the two groups were evaluated using the Fisher exact test for each time period.
</p>
